CNN Central News & Network–ITDC India Epress/ITDC News Bhopal: Under the guidance of Executive Director Ajay Singh, AIIMS Bhopal organized a workshop on “Cytology Screening through AI – Advancements in Cancer Screening and Diagnosis.”

The event highlighted how Artificial Intelligence (AI) can now detect cancer using just a drop of blood, utilizing cutting-edge liquid biopsy technology. This innovation could eliminate the need for expensive CT scans and MRIs, making cancer diagnosis faster, more accurate, and widely accessible.

Leading the initiative, Prof. Ajay Singh emphasized AI’s critical role in modern healthcare, stating:

“This revolutionary technology has the potential to transform cancer diagnosis entirely. It can detect cancer in its early stages, even in asymptomatic patients. By making cancer screening faster and more accessible, we can save countless lives, especially in remote and underserved areas.”

Key Highlights of the Workshop:

✅ AI-driven early cancer detection, enabling timely treatment and higher survival rates.

✅ Use of machine learning algorithms for accurate cancer identification and risk prediction based on genetics and lifestyle factors.

✅ Live demonstrations of digital pathology AI technology, producing high-resolution cellular images for rapid diagnosis.

✅ Introduction of two state-of-the-art AI systems:

OptoScan Ultra – Designed for large laboratories, capable of scanning 80 to 480 slides at once.

OptoScan Lite – Designed for smaller labs, with a 15-slide capacity.

The Department of Biochemistry and Pathology at AIIMS Bhopal jointly organized the workshop, featuring expert lectures and hands-on training. Key contributors included Prof. Jagat R. Kanwar (Workshop Chair), Sukhes Mukherjee (Coordinator, Biochemistry), Prof. Vaishali Walke, Jay Chaurasia, and Shakti Kumar Yadav (Pathology Department), and external resource expert Neelam Kolte.

More than 40 pathologists, oncologists, and National Health Mission (NHM) specialists from across India participated, demonstrating the growing interest in AI-based cancer diagnostics.

Global AI Innovations in Cancer Diagnosis:

🔹 Google’s LYNA (Lymph Node Assistant)

🔹 IBM Watson for Oncology

🔹 Stanford’s CheXNet

These advanced AI systems have already revolutionized cancer detection in the U.S. and Europe. Now, AIIMS Bhopal is bringing this technology to India, ensuring advanced cancer diagnostics reach even small clinics and rural hospitals.

Impact of AI-Driven Cancer Screening:

✔ Faster, highly accurate, and cost-effective diagnosis.

✔ Eliminates the need for expensive CT scans and MRIs.

✔ Reduces reliance on manual diagnostic methods.

✔ Improves accessibility to advanced healthcare in rural areas.

At the workshop’s conclusion, Prof. Jagat R. Kanwar remarked:

“AI is revolutionizing cancer diagnosis and treatment. This technology will continue to evolve, saving millions of lives in the coming years. AI-driven diagnostics will enable personalized treatments, leading to faster recovery and fewer side effects from traditional chemotherapy.”

#AIIMSBhopal #CancerScreening #AIHealthcare #MedicalWorkshop #EarlyDetection